Information Journal Paper
APA:
Copy. (2019). Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis. FRONT ONCOL, 9(-), 1557-1557. SID. https://sid.ir/paper/658227/en
Vancouver:
Copy. Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis. FRONT ONCOL[Internet]. 2019;9(-):1557-1557. Available from: https://sid.ir/paper/658227/en
IEEE:
Copy, “Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis,” FRONT ONCOL, vol. 9, no. -, pp. 1557–1557, 2019, [Online]. Available: https://sid.ir/paper/658227/en